RÉSUMÉ
Icariin has been shown the promising therapeutic potential to treat inflammatory airway diseases, yet its poor lung distribution and retention restrict the clinical applications. To this end, this work aimed to prepare an icariin-phospholipid complex (IPC) formulation for sustained nebulization delivery that enabled excellent inhalability, improved lung exposure and prolonged duration of action. Icariin was found to react with soybean phospholipid to form supramolecular IPC, which was able to self-assemble into nanoparticle suspension. The suspension was stable during steam sterilization and nebulization processes, and its aerosols generated by a commercial nebulizer exhibited excellent aerodynamic properties and delivery efficiency. In vitro studies showed that the formation of complex sustained drug release, enhanced lung affinity and slowed lung clearance. The drug distribution in lung epithelial lining fluid (ELF) also demonstrated in vivo sustained release after intratracheal administration to mice. In addition, compared to free icariin, IPC improved the drug exposure to lung tissues and immune cells in the ELF by 4.61-fold and 39.5-fold, respectively. This resulted in improved and prolonged local anti-inflammatory effects up to 24â¯h in mice with lipopolysaccharide (LPS)-induced acute lung injury. Moreover, IPC improved survival rate of mice with acute respiratory distress syndrome (ARDS). Overall, the present phospholipid complex represented a promising formulation of icariin for the treatment of acute lung injury/ARDS by nebulization delivery.
Sujet(s)
Lésion pulmonaire aigüe , Flavonoïdes , Poumon , Phospholipides , , Animaux , Flavonoïdes/administration et posologie , Flavonoïdes/composition chimique , Flavonoïdes/pharmacologie , Phospholipides/composition chimique , Lésion pulmonaire aigüe/traitement médicamenteux , Souris , Poumon/effets des médicaments et des substances chimiques , Poumon/métabolisme , Poumon/anatomopathologie , /traitement médicamenteux , Administration par inhalation , Mâle , Systèmes de délivrance de médicaments , Lipopolysaccharides/pharmacologie , Taille de particule , Souris de lignée BALB CRÉSUMÉ
Due to the unique physiological barriers within the lungs, there are considerable challenges in developing drug delivery systems enabling prolonged drug exposure to respiratory epithelial cells. Here, we report a PulmoSphere-based dry powder technology that incorporates a drug-phospholipid complex to promote intracellular retention of dehydroandrographolide succinate (DAS) in respiratory epithelial cells following pulmonary delivery. The DAS-phospholipid complex has the ability to self-assemble into nanoparticles. After spray-drying to produce PulmoSphere microparticles loaded with the drug-phospholipid complex, the rehydrated microparticles discharge the phospholipid complex without altering its physicochemical properties. The microparticles containing the DAS-phospholipid complex exhibit remarkable aerodynamic properties with a fine particle fraction of â¼ 60% and a mass median aerodynamic diameter of â¼ 2.3 µm. These properties facilitate deposition in the alveolar region. In vitro cell culture and lung tissue explants experiments reveal that the drug-phospholipid complex prolongs intracellular residence time and lung tissue retention due to the slow intracellular disassociation of drug from the complex. Once deposited in the lungs, the DAS-phospholipid complex loaded microparticles increase and extend drug exposure to the lung tissues and the immune cells compared to the free DAS counterpart. The improved drug exposure to airway epithelial cells, but not immune cells, is related to a prolonged duration of pulmonary anti-inflammation at decreased doses in a mouse model of acute lung injury induced by lipopolysaccharide. Overall, the phospholipid complex loaded microparticles present a promising approach for improved treatment of respiratory diseases, e.g. pneumonia and acute respiratory distress syndrome.
RÉSUMÉ
L-type amino acid transporter 1 (LAT1) is specifically expressed in many malignancies, contributes to the transport of essential amino acids, such as leucine, and regulates the mammalian target of rapamycin (mTOR) signaling pathway. We investigated the expression profile and functional role of LAT1 in prostate cancer using JPH203, a specific inhibitor of LAT1. LAT1 was highly expressed in castration-resistant prostate cancer (CRPC) cells, including C4-2 and PC-3 cells, but its expression level was low in castration-sensitive LNCaP cells. JPH203 significantly inhibited [14C] leucine uptake in CRPC cells but had no effect in LNCaP cells. JPH203 inhibited the proliferation, migration, and invasion of CRPC cells but not of LNCaP cells. In C4-2 cells, Cluster of differentiation (CD) 24 was identified by RNA sequencing as a novel downstream target of JPH203. CD24 was downregulated in a JPH203 concentration-dependent manner and suppressed activation of the Wnt/ß-catenin signaling pathway. Furthermore, an in vivo study showed that JPH203 inhibited the proliferation of C4-2 cells in a castration environment. The results of this study indicate that JPH203 may exert its antitumor effect in CRPC cells via mTOR and CD24.
Sujet(s)
Antigènes CD24 , Mouvement cellulaire , Prolifération cellulaire , Transporteur-1 d'acides aminés neutres à longue chaîne , Tumeurs prostatiques résistantes à la castration , Mâle , Humains , Tumeurs prostatiques résistantes à la castration/traitement médicamenteux , Tumeurs prostatiques résistantes à la castration/métabolisme , Tumeurs prostatiques résistantes à la castration/anatomopathologie , Transporteur-1 d'acides aminés neutres à longue chaîne/métabolisme , Lignée cellulaire tumorale , Animaux , Prolifération cellulaire/effets des médicaments et des substances chimiques , Antigènes CD24/métabolisme , Souris , Mouvement cellulaire/effets des médicaments et des substances chimiques , Voie de signalisation Wnt/effets des médicaments et des substances chimiques , Tests d'activité antitumorale sur modèle de xénogreffe , Sérine-thréonine kinases TOR/métabolisme , Sérine-thréonine kinases TOR/antagonistes et inhibiteurs , Benzoxazoles/pharmacologie , Leucine/pharmacologie , Leucine/analogues et dérivés , Souris nude , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Tyrosine/analogues et dérivésRÉSUMÉ
BACKGROUND: Dietary restriction (DR), a general term for dieting, has been demonstrated as an effective intervention in reducing the occurrence of cancers. Molecular activities associated with DR are crucial in mediating its anti-cancer effects, yet a comprehensive exploration of the landscape of these activities at the pan-cancer level is still lacking. METHODS: We proposed a computational approach for quantifying DR-related molecular activities and delineating the landscape of these activities across 33 cancer types and 30 normal tissues within 27,320 samples. We thoroughly examined the associations between DR-related molecular activities and various factors, including the tumour microenvironment, immunological phenotypes, genomic features, and clinical prognosis. Meanwhile, we identified two DR genes that show potential as prognostic predictors in hepatocellular carcinoma and verified them by immunohistochemical assays in 90 patients. FINDINGS: We found that DR-related molecular activities showed a close association with tumour immunity and hold potential for predicting immunotherapy responses in various cancers. Importantly, a higher level of DR-related molecular activities is associated with improved overall survival and cancer-specific survival. FZD1 and G6PD are two DR genes that serve as biomarkers for predicting the prognosis of patients with hepatocellular carcinoma. INTERPRETATION: This study presents a robust link between DR-related molecular activities and tumour immunity across multiple cancer types. Our research could open the path for further investigation of DR-related molecular processes in cancer treatment. FUNDING: National Natural Science Foundation of China (Grant No. 82000628) and the Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine Foundation of Guangdong Province (Grant No. 2023LSYS001).
Sujet(s)
Carcinome hépatocellulaire , Tumeurs du foie , Humains , Carcinome hépatocellulaire/génétique , Transcriptome , Analyse de profil d'expression de gènes , Microenvironnement tumoral/génétique , Pronostic , Tumeurs du foie/génétiqueRÉSUMÉ
The three enzymes galactose oxidase (GO), catalase (CAT), and Mn-superoxide dismutase (SOD) were simultaneously immobilized by coordinating to CuII in phosphate buffer saline. The biocatalyst GO&CAT&SOD@CuII was used for the conversion of 5-hydroxymethylfurfural (HMF). The immobilized GO catalyzes the oxidation of HMF to 2,5-diformylfuran (DFF), concomitantly the co-substrate O2 is reduced to hydrogen peroxide (H2O2). A portion of the byproduct H2O2 is broken down to O2 and H2O by the co-immobilized CAT, and the evolved O2 can be recycled and used as the co-substrate. A portion of the byproduct H2O2 is broken down to produce hydroxyl radicals â¢OH under the synergistic catalysis of the immobilized SOD and coordinated CuII, and the produced â¢OH can reactivate the immobilized galactose oxidase. Two aspects contribute to the high catalytic efficiency by GO&CAT&SOD@CuII: the reactivation of the immobilized galactose oxidase by producing â¢OH and the enrichment of the co-substate O2 by recycling the produced O2. For the conversion of 10 mM HMF, GO&CAT&SOD@CuII (with encapsulated GO 0.2 mg/mL) achieved 97% HMF conversion within 2 h reaction. In contrast, free galactose oxidase M3-5 variant (ACS Catalysis 2018, 8, 4025) (0.2 mg/mL) achieved 25.3% HMF conversion within 2 h reaction. All the reactions were carried out in pure water, not in PBS.
Sujet(s)
Galactose oxidase , Eau , Catalase , Peroxyde d'hydrogène , Superoxide dismutaseRÉSUMÉ
BACKGROUND: The DEAD-box family is essential for tumorigenesis and embryogenesis. Previously, we linked the malfunction of DDX (DEAD-box RNA helicase)-24 to a special type of vascular malformation. Here, we aim to investigate the function of DDX24 in vascular smooth muscle cells (VSMCs) and embryonic vascular development. METHODS: Cardiomyocyte (CMC) and VSMC-specific Ddx24 knockout mice were generated by crossing Tagln-Cre mice with Ddx24flox/flox transgenic mice. The development of blood vessels was explored by stereomicroscope photography and immunofluorescence staining. Flow cytometry and cell proliferation assays were used to verify the regulation of DDX24 on the function of VSMCs. RNA sequencing and RNA immunoprecipitation coupled with quantitative real-time polymerase chain reaction were combined to investigate DDX24 downstream regulatory molecules. RNA pull-down and RNA stability experiments were performed to explore the regulation mechanism of DDX24. RESULTS: CMC/VSMC-specific Ddx24 knockout mice died before embryonic day 13.5 with defects in vessel formation and abnormal vascular remodeling in extraembryonic tissues. Ddx24 knockdown suppressed VSMC proliferation via cell cycle arrest, likely due to increased DNA damage. DDX24 protein bound to and stabilized the mRNA of FANCA (FA complementation group A) that responded to DNA damage. Consistent with the function of DDX24, depletion of FANCA also impacted cell cycle and DNA repair of VSMCs. Overexpression of FANCA was able to rescue the alterations caused by DDX24 deficiency. CONCLUSIONS: Our study unveiled a critical role of DDX24 in VSMC-mediated vascular development, highlighting a potential therapeutic target for VSMC-related pathological conditions.
Sujet(s)
Muscles lisses vasculaires , Myocytes du muscle lisse , Souris , Animaux , Muscles lisses vasculaires/métabolisme , ARN messager/génétique , ARN messager/métabolisme , Points de contrôle du cycle cellulaire , Souris transgéniques , Souris knockout , Cycle cellulaire , Myocytes du muscle lisse/métabolisme , Prolifération cellulaire , Cellules cultivéesRÉSUMÉ
Amblyseius orientalis (Ehara) (Acari: Phytoseiidae) is an effective predatory mite for spider mite control on fruit trees in China. In recent decades, it has been produced massively at a commercial natural enemy producer, feeding on the storage mite Carpoglyphus lactis (L.). In the predator production process, the ratio of predatory mites to their prey was found to be critical for the population increase of A. orientalis in large-scale rearings. In this study, we investigated the predatory capacity of A. orientalis on various developmental stages of the prey C. lactis, and the effect of prey numbers on predator reproduction. The maximum predation rate of A. orientalis adults on C. lactis adults was 2.21 per day at the lowest density of five prey adults, and on C. lactis eggs it was 45.07 at the highest density of 60 prey eggs. The preference index Ci of A. orientalis on C. lactis eggs and adults was 0.4312 and - 0.9249, respectively, suggesting that A. orientalis preferred eggs to adults. Amblyseius orientalis could reproduce when it preyed on either eggs or deutonymphs of C. lactis. However, the fecundity of the predatory mites is not always proportional to the provided prey number. Higher density of prey deutonymphs resulted in lower fecundity, whereas more prey eggs resulted in higher fecundity of A. orientalis. Therefore, our study indicated that the choice of suitable density and developmental stage of prey can significantly improve A. orientalis production on a large scale.
Sujet(s)
Acaridae , Tetranychidae , Animaux , Comportement prédateur , Lutte biologique contre les nuisibles , ReproductionRÉSUMÉ
The L-type amino acid transporter (LAT) family contains four members, LAT1~4, which are important amino acid transporters. They mainly transport specific amino acids through cell membranes, provide nutrients to cells, and are involved in a variety of metabolic pathways. They regulate the mTOR signaling pathway which has been found to be strongly linked to cancer in recent years. However, in the field of prostate cancer (PCa), the LAT family is still in the nascent stage of research, and the importance of LATs in the diagnosis and treatment of prostate cancer is still unknown. Therefore, this article aims to report the role of LATs in prostate cancer and their clinical significance and application. LATs promote the progression of prostate cancer by increasing amino acid uptake, activating the mammalian target of rapamycin (mTOR) pathway and downstream signals, mediating castration-resistance, promoting tumor angiogenesis, and enhancing chemotherapy resistance. The importance of LATs as diagnostic and therapeutic targets for prostate cancer was emphasized and the latest research results were introduced. In addition, we introduced selective LAT1 inhibitors, including JPH203 and OKY034, which showed excellent inhibitory effects on the proliferation of various tumor cells. This is the future direction of amino acid transporter targeting therapy drugs.
Sujet(s)
Tumeurs de la prostate , Mâle , Humains , Tumeurs de la prostate/diagnostic , Tumeurs de la prostate/génétique , Tumeurs de la prostate/thérapie , Sérine-thréonine kinases TOR/génétique , Sérine-thréonine kinases TOR/métabolisme , Acides aminés/métabolisme , Transduction du signal , Systèmes de transport d'acides aminés/génétique , Systèmes de transport d'acides aminés/métabolismeRÉSUMÉ
2,5-Furandicarboxylic acid (FDCA) can be used for synthesis of various polyesters and polyamides. It can be produced from oxidation of 5-hydroxymethylfurfural (HMF), a biomass-based platform chemical. In this work, a new catalyst CotA laccase/TEMPO/catalase has been presented and used for efficient and selective oxidation of HMF to FDCA. Dioxygen O2, which is in-situ generated from the decomposition of H2O2 by catalase, is used as the oxidant. In comparison to using ambient air as the oxidant, using the in-situ generated O2 as the oxidant has significantly increased the catalytic efficiency. Dioxygen O2 can be generated in a convenient and easy way using clean H2O2 as the source. It has been found that continuous generation of O2 is essential, and over generation of O2 is not necessary because of the limitation of the O2 diffusion into the inner space of CotA laccase. It has been demonstrated that, by coupling with the electron transfer mediator TEMPO and catalase, the bacterial laccase can efficiently oxidize HMF to produce FDCA.
Sujet(s)
Peroxyde d'hydrogène , Laccase , Laccase/composition chimique , Catalase , Furanes , Oxygène , OxydantsRÉSUMÉ
Heart failure (HF) is a globally prevalent cardiovascular disease, but effective drug targets and diagnostic models are still lacking. This study was designed to investigate effective drug targets and diagnostic models for HF in terms of miRNA targets, hoping to contribute to the understanding and treatment of HF. Using HF miRNA and gene expression profile data from the GEO database, we analyzed differentially expressed miRNAs/gene identification in HF using Limma and predicted miRNA targets by the online TargetScan database. Subsequently, gene set enrichment analysis and annotation were performed using WebGestaltR package. Protein-protein interactions were identified using the STRING database. The proximity of drugs to treat HF was also calculated and predicted for potential target therapeutic drug. In addition, further drug identification was performed by molecular docking. Finally, diagnostic models were constructed based on differential miRNAs. The GEO dataset was used to screen 66 differentially expressed miRNAs, incorporating 56 downregulated miRNAs and 10 upregulated miRNAs. The JAK-STAT signaling pathway, MAPK signaling pathway, p53 signaling pathway, Prolactin signaling pathway, and TGF-beta signaling pathway were enriched, as shown by KEGG enrichment analysis on the target genes. In addition, we found that 83 genes were upregulated and 92 genes were downregulated in HF patients vs. healthy individuals. Based on the inflammation-related score, hypoxia-related score, and energy metabolism-related score, we identified key miRNA-mRNA pairs and constructed an interaction network. Following that, TAP1, which had the highest expression and network connectivity in acute HF with crystal and molecular docking studies, was selected as a key candidate gene in the network. And the compound DB04847 was selected to produce a large number of favorable interactions with TAP1 protein. Finally, we constructed two diagnostic models based on the differential miRNAs hsa-miR-6785-5p and hsa-miR-4443. In conclusion, we identified TAP1, a key candidate gene in the diagnosis and treatment of HF, and determined that compound DB04847 is highly likely to be a potential inhibitor of TAP1. The TAP1 gene was also found to be regulated by hsa-miR-6785-5p and hsa-miR-4443, and a diagnostic model was constructed. This provides a new promising direction to improve the diagnosis, prognosis, and treatment outcome and guide more effective immunotherapy strategies of HF.
Sujet(s)
Défaillance cardiaque , microARN , Membre-2 de la sous-famille B à cassette de liaison à l'ATP/génétique , Réseaux de régulation génique , Défaillance cardiaque/génétique , Humains , microARN/génétique , microARN/métabolisme , Simulation de docking moléculaire , Prolactine/métabolisme , ARN messager/génétique , Facteur de croissance transformant bêta/métabolisme , Protéine p53 suppresseur de tumeur/génétiqueRÉSUMÉ
Very little is currently known about how inhaled nanomedicine for lung cancer treatment overcomes biological barriers hampering the tumor availability of drug and nanoparticles. Here, we developed a size-transformable nanocarrier (~ 119 nm) in which small-size nanoparticles (~ 28 nm) were loaded in the large nanocarrier after the addition of modified hyaluronan and could be released upon size-transformation at tumor tissue. Subsequently, the pulmonary and tumor pharmacokinetics of the two nanocarriers containing 7-ethyl-10-hydroxycamptothecin (SN38) and a covalently linked fluorescent sonosensitizer were comparatively investigated after intratracheal instillation to mice bearing orthotopic Lewis lung carcinoma tumors. The results showed that both instilled nanoparticles seemed to transport drug to tumor by direct access and transcytosis of nanoparticles, and diffusion of the released drug with the latter accounting for a great proportion of the drug tumor bioavailability. Relative to the small-size nanocarrier, the size-transformable counterpart appeared to restrict the mucociliary and absorption clearances from the lung and the clearance from the tumor interstitium to circulation, leading to increases in lung and tumor bioavailability of SN38 by 58.5% and 199%, respectively. In addition, the size-transformable nanoformulation conferred deep tumor penetration and sustained levels of both sonosensitizer and SN38 within tumors and simultaneously exerted sonodynamic- and chemo-therapies. Overall, the pulmonary delivery of size-transformable nanocarrier could co-deliver sonosensitizer and drug to deep tumor sites with enhanced tumor accumulation to realize combination therapy in lung cancer.
Sujet(s)
Tumeurs du poumon , Nanoparticules , Animaux , Lignée cellulaire tumorale , Acide hyaluronique , Irinotécan , Poumon , Tumeurs du poumon/traitement médicamenteux , SourisRÉSUMÉ
Diabetic nephropathy (DN) has become the main cause of end-stage renal disease worldwide. Inflammation is associated with the occurrence and development of DN, and long noncoding RNAs (lncRNAs) are involved in the regulation of inflammatory processes. This study aims to determine the role and mechanism of lncRNA-CES1P1 in DN.C57BL/6 mice and human umbilical vein endothelial cells (HUVECs) were used for this experimental study. In vivo experimental intraperitoneal injection of streptozotocin (STZ) to construct a diabetes mellitus (DM) model in C57BL/6 mice caused increased expression of lncRNA-CES1P1, decreased expression of miR-214-3p in kidney tissue, and produced renal inflammation and proteinuria. Exogenous knockdown of lncRNA-CES1P1 expression decreased renal inflammatory infiltration. In vitro experiments using high glucose (HG) stimulation of HUVECs cell revealed increased expression of lncRNA-CES1P1, decreased expression of miR-214-3p, and increased expression of the inflammatory factors IL-17, IκB, NF-κB, and IL-6. Luciferase reporter assays showed direct targets of miR-214-3p interaction with lncRNA-CES1P1 and IL-17. These results suggest that hyperglycemia represses miR-214-3p by inducing lncRNA-CES1P1, which promotes the expression of the inflammatory factors IL-17, IκB, NF-κB and IL-6 ultimately leading to the development of DN. Interfering with lncRNA-CES1P1 can reduce hyperglycemia-induced DN.
Sujet(s)
Diabète , Néphropathies diabétiques , Hyperglycémie , microARN , ARN long non codant , Animaux , Néphropathies diabétiques/génétique , Néphropathies diabétiques/métabolisme , Cellules endothéliales/métabolisme , Humains , Hyperglycémie/génétique , Inflammation/génétique , Interleukine-17 , Interleukine-6 , Souris , Souris de lignée C57BL , microARN/génétique , microARN/métabolisme , Facteur de transcription NF-kappa B , ARN long non codant/génétique , ARN long non codant/métabolismeRÉSUMÉ
Type 2 diabetes mellitus (T2DM) has an increased risk of cancer. In the present study, the relationship between T2DM and 13 types of cancer was analyzed and key methylation genes were searched. First, DNA methylation and mRNA expression were obtained data for T2DM and 13 types of cancer from The Cancer Genome Atlas and Gene Expression Omnibus. The t-test was used to screen the differentially methylated expression overlapping genes (DE-MGs) in T2DM and cancer on both methylation and expression levels. DE-MGs are weighted based on the methylation and projected into the human protein interaction network. The correlation between T2DM and each type of cancer was analyzed, and key genes were identified. The results showed that 293 DE-MGs were related to T2DM and 3307 were related to cancer. The network found that T2DM is more related to colorectal cancer (CRC) compare with the other 12 types of cancer. A total of 5 from 8 candidate genes were associated with CRC. A total of 28 clinical patients were used to validate these 5 genes. A CRC tissue sample was collected from each patient, as well as a paracancerous sample that served as a control. A total of 56 tissue samples were divided into 4 groups: control group, T2DM group, CRC group and T2DM with CRC group (combination group). Compared with the control group, the methylation level of adenylate cyclase 5 (ADCY5), neuregulin 1 and ELAV-like RNA-binding protein 4 in the combination group was significantly upregulated, and the mRNA level was significantly downregulated. Furthermore, based on the methylation level of ADCY5, the correlation coefficient between the combination group and the T2DM group was greater than that of the CRC group. In conclusion, T2DM is most likely to be associated with CRC among 13 common types of cancer based on methylation characteristics. An upregulated methylation of ADCY5 in T2DM may have a higher risk of CRC.
RÉSUMÉ
Objective: To investigate the expression level of miR-4739 in gastric cancer (GC), analyze its diagnostic value in GC and the relationship with clinical pathological characteristics, and analyze its impact on the prognosis of patients. Methods: A total of 96 patients with GC who underwent radical gastrectomy in our hospital from March 2017 to June 2021 were selected. GC tissues from all patients were collected, and normal tissues adjacent to cancer were collected as controls. The expression level of miR-4739 in tissues was detected, the relationship between miR-4739 and different pathological features was analyzed, and the diagnostic value of miR-4739 in GC was analyzed. All patients were followed up after the operation, and the survival time of the patients was set as from the day of the first operation to 1â d when the patients died or the follow-up ended. Results: The relative expression level of miR-4739 in the GC tissue was (0.39 ± 0.06), lower than that in the paracancerous tissue (1.18 ± 0.19) (P < 0.05). The AUC of miR-4739 in the diagnosis of GC was 0.705. When the Youden index was 0.320 and the optimal cutoff value was 0.37, the sensitivity was 95.30% and the specificity was 36.70%. The expression level of miR-4739 in our patient was related to the differentiation degree, lymph node metastasis, tumor diameter, and TNM stage (P < 0.05). During the follow-up period, 26 of 96 patients died, and the survival rate was 72.92% (26/96). The median survival time was 29 months in the miR-4739 LE group, which was shorter than 39 months in the miR-4739 HE group (P < 0.05). Univariate analysis showed that age, degree of differentiation, lymph node metastasis, tumor diameter, TNM staging, and miR-4739 expression were all related to the prognosis of the patient (P < 0.05). Multivariate analysis showed that differentiation degree, lymph node metastasis, tumor diameter, TNM staging, and miR-4739 expression were all independent factors affecting the prognosis of the patients (P < 0.05). Conclusion: The expression of miR-4739 in GC tissue was down-regulated, and its level was related to the degree of differentiation, lymph node metastasis, tumor diameter, and TNM stage. The expression level of miR-4739 has certain diagnostic value for patients with GC, and the prognosis of patients in LE group was worse than that in HE group.
RÉSUMÉ
Graves ophthalmopathy (GO), a manifestation of Graves' disease, is an organ-specific autoimmune disease. Intravenous glucocorticoid therapy (ivGCs) is the first-line treatment for moderate-to-severe and active GO. However, ivGCs is only effective in 70%-80% of GO patients. Insensitive patients who choose 12-week ivGCs not only were delayed in treatment but also took the risk of adverse reactions of glucocorticoids. At present, there is still a lack of effective indicators to predict the therapeutic effect of ivGCs. Therefore, the purpose of this study is to find biomarkers that can determine the sensitivity of ivGCs before the formulation of treatment, and to clarify the mechanism of its regulation of ivGCs sensitivity. This study first characterized the miRNA profiles of plasma exosomes by miRNA sequencing to identify miRNAs differentially expressed between GO patients with significant improvement (SI) and non-significant improvement (NSI) after ivGCs treatment. Subsequently, we analyzed the function of the predicted target genes of differential miRNAs. According to the function of the target genes, we screened 10 differentially expressed miRNAs. An expanded cohort verification showed that compared with NSI patients, mir-885-3p was upregulated and mir-4474-3p and mir-615-3p were downregulated in the exosomes of SI patients. Based on statistical difference and miRNA function, mir-885-3p was selected for follow-up study. The in vitro functional analysis of exosomes mir-885-3p showed that exosomes from SI patients (SI-exo) could transfer mir-885-3p to orbital fibroblasts (OFs), upregulate the GRE luciferase reporter gene plasmid activity and the level of glucocorticoid receptor (GR), downregulate the level of inflammatory factors, and improve the glucocorticoid sensitivity of OFs. Moreover, these effects can be inhibited by the corresponding miR inhibitor. In addition, we found that high levels of mir-885-3p could inhibit the AKT/NFκB signaling pathway, upregulate the GRE plasmid activity and GR level, and downregulate the level of inflammatory factors of OFs. Moreover, the improvement of glucocorticoid sensitivity by mir-885-3p transmitted by SI-exo can also be inhibited by the AKT/NFκB agonist. Finally, through the in vivo experiment of the GO mouse model, we further determined the relationship between exosomes' mir-885-3p sequence, AKT/NFκB signaling pathway, and glucocorticoid sensitivity. As a conclusion, plasma exosomes deliver mir-885-3p and inhibit the AKT/NFκB signaling pathway to improve the glucocorticoid sensitivity of OFs. Exosome mir-885-3p can be used as a biomarker to determine the sensitivity of ivGCs in GO patients.
Sujet(s)
Exosomes , Ophtalmopathie basedowienne , microARN , Animaux , Exosomes/métabolisme , Études de suivi , Glucocorticoïdes/métabolisme , Glucocorticoïdes/pharmacologie , Glucocorticoïdes/usage thérapeutique , Ophtalmopathie basedowienne/traitement médicamenteux , Ophtalmopathie basedowienne/génétique , Ophtalmopathie basedowienne/métabolisme , Humains , Souris , microARN/génétique , microARN/métabolisme , Facteur de transcription NF-kappa B/métabolisme , Protéines proto-oncogènes c-akt/métabolisme , Transduction du signalRÉSUMÉ
The variations in the degradation of electrical characteristics resulting from different device structures for trench-gate SiC metal-oxide-semiconductor field effect transistors (MOSFETs) are investigated in this work. Two types of the most advanced commercial trench products, which are the asymmetric trench SiC MOSFET and the double-trench SiC MOSFET, are chosen as the targeted devices. The discrepant degradation trends caused by the repetitive avalanche stress are monitored. For the double-trench device, the conduction characteristic improves while the gate-drain capacitance (Cgd) increases seriously. It is because positive charges are injected into the bottom gate oxide during the avalanche process, which are driven by the high oxide electronic field (Eox) and the high impact ionization rate (I.I.) there. Meanwhile, for the asymmetric trench SiC MOSFET, the I-V curve under the high gate bias condition and the Cgd remain relatively stable, while the trench bottom is well protected by the deep P+ well. However, it's threshold voltage (Vth) decreases more obviously when compared with that of the double-trench device and the inclined channel suffers from more serious stress than the vertical channel. Positive charges are more easily injected into the inclined channel. The phenomena and the corresponding mechanisms are analyzed and proved by experiments and technology computer-aided design (TCAD) simulations.
RÉSUMÉ
Diabetes mellitus impairs fracture healing and function of stem cells related to bone regeneration; thus, effective bone tissue engineering therapies can intervene with those dysfunctions. Nanohydroxyapatite/polyamide 66 (n-HA/PA66) scaffold has been used in fracture healing, whereas the low bioactivity limits its further application. Herein, we developed a novel bone morphogenetic protein-2- (BMP-2) and vascular endothelial growth factor- (VEGF) derived peptides-decorated n-HA/PA66 (BVHP66) scaffold for diabetic fracture. The n-HA/PA66 scaffold was functionalized by covalent grafting of BMP-2 and VEGF peptides to construct a dual peptide sustained-release system. The structural characteristics and peptide release profiles of BVHP66 scaffold were tested by scanning electron microscopy, Fourier transform infrared spectroscopy, and fluorescence microscope. Under high glucose (HG) condition, the effect of BVHP66 scaffold on rat bone marrow mesenchymal stem cells' (rBMSCs) adherent, proliferative, and differentiate capacities and human umbilical vein endothelial cells' (HUVECs) proliferative and tube formation capacities was assessed. Finally, the BVHP66 scaffold was applied to fracture of diabetic rats, and its effect on osteogenesis and angiogenesis was evaluated. In vitro, the peptide loaded on the BVHP66 scaffold was in a sustained-release mode of 14 days. The BVHP66 scaffold significantly promoted rBMSCs' and HUVECs' proliferation and improved osteogenic differentiation of rBMSCs and tube formation of HUVECs in HG environment. In vivo, the BVHP66 scaffold enhanced osteogenesis and angiogenesis, rescuing the poor fracture healing in diabetic rats. Comparing with single peptide modification, the dual peptide-modified scaffold had a synergetic effect on bone regeneration in vivo. Overall, this study reported a novel BVHP66 scaffold with excellent biocompatibility and bioactive property and its application in diabetic fracture.
RÉSUMÉ
Photocatalytic degradation of multiple organic contaminants has received extensive research attention and rational design of visible-light driven photocatalyst has been considered as an efficient approach. In this study, a visible-light Ag2O/Bi2WO6 heterostructure incorporated reduced graphene oxide (ABW-RGO) composite photocatalyst was prepared through a facile hydrothermal method for the first time and exhibited synergetic degradation behavior for contaminants in aqueous solutions. Under visible light, Tetracycline antibiotics has degraded 95.3% within only 40 min, and dye pollutants including Crystal Violet (cationic dye) and Congo Red (anionic dye) reached over 98.5% decomposition. The synthesized composite is also highly efficient in a wide pH range and multi-components system, maximizing the utilization of common sunlight, which make it suitable for industrial wastewater. The reactive oxidant species (ROS) experiment and electron spin resonance (ESR) measurement revealed the critical role of hydroxyl and superoxide radicals, clarifying the degradation pathway and mechanism analysis. The superior photocatalytic activity could be attributed to the formation of effective Z-scheme heterostructure and the excellent sorption capacity and conductivity of reduced graphene oxide. This research provides the design pathway to a novel catalyst using semiconductors composite and graphene support material, which can be extended to the energy-saving treatment of various organic pollutants.
RÉSUMÉ
BACKGROUND: College students in China are emerging as one of the most vulnerable groups to contract HIV, because they are in a sexually active age group and also because of their open attitude toward sex and high risk sexual behaviors. This study aimed to explore the prevalence of willingness among college students to utilize HIV testing and counseling (HTC) service and the factors that may affect willingness, including predisposing, enabling and need factors, based on the Andersen's behavioral model. METHODS: A cross-sectional study was conducted from October 6, 2016 to December 31, 2016 in Hubei University of Science and Technology in China. After signing informed consent, college students completed a self-designed online questionnaire distributed via https://www.wjx.cn/ voluntarily, anonymously and confidentially. Pearson's chi-square test and Logistic regression models were chosen to analyze the factors associated with willingness to utilize HTC service. RESULTS: Out of 3314 college students in the sample, 2583 (77.9%) expressed their willingness to utilize HTC service. After adjustment, those with low levels of discrimination towards people living with HIV (PLHIV) (OR = 1.41, 95%CI:1.17-1.68), being more knowledgeable about free HTC service centers (OR = 1.44, 95%CI:1.17-1.77), having recognized the necessity to provide HTC service in the local university (OR = 2.20, 95%CI:1.73-2.80), and having a higher HIV risk perception (OR = 1.64, 95%CI:1.37-1.95) were more willing to utilize HTC service, compared with their respective counterparts. CONCLUSIONS: In order to improve their willingness to utilize HTC service and finally to achieve the goal of zero-AIDS, a comprehensive intervention measure should be taken to publicize HTC service, eliminate stigma and discrimination against PLHIV, recruit and train peer volunteers to serve in the local university, and increase self-perceived risk of HIV infection.
Sujet(s)
Assistance/statistiques et données numériques , Infections à VIH/prévention et contrôle , Dépistage de masse/statistiques et données numériques , Acceptation des soins par les patients/statistiques et données numériques , Étudiants/psychologie , Adolescent , Adulte , Chine , Études transversales , Femelle , Infections à VIH/psychologie , Connaissances, attitudes et pratiques en santé , Humains , Mâle , Prévalence , Appréciation des risques , Stigmate social , Étudiants/statistiques et données numériques , Enquêtes et questionnaires , Universités , Jeune adulteRÉSUMÉ
Green roofs have increasingly been designed and applied to relieve environmental problems, such as water loss, air pollution as well as heat island effect. Substrate and vegetation are important components of green roofs providing ecosystem services and benefiting the urban development. Biochar made from sewage sludge could be potentially used as the substrate amendment for green roofs, however, the effects of biochar on substrate quality and plant performance in green roofs are still unclear. We evaluated the effects of adding sludge biochar (0, 5, 10, 15 and 20%, v/v) to natural soil planted with three types of plant species (ryegrass, Sedum lineare and cucumber) on soil properties, plant growth and microbial communities in both green roof and ground ecosystems. Our results showed that sludge biochar addition significantly increased substrate moisture, adjusted substrate temperature, altered microbial community structure and increased plant growth. The application rate of 10-15% sludge biochar on the green roof exerted the most significant effects on both microbial and plant biomass by 63.9-89.6% and 54.0-54.2% respectively. Path analysis showed that biochar addition had a strong effect on microbial biomass via changing the soil air-filled porosity, soil moisture and temperature, and promoted plant growth through the positive effects on microbial biomass. These results suggest that the applications of biochar at an appropriate rate can significantly alter plant growth and microbial community structure, and increase the ecological benefits of green roofs via exerting effects on the moisture, temperature and nutrients of roof substrates.